Relievant Medsystems IPO

Relievant Medsystems is a medical device company developing a novel treatment designed to improve the quality of life for patients suffering from Chronic Low Back Pain from degenerative disk disease with Modic changes, a biomarker indicating that their pain is vertebrogenic in origin.

Register for Details

For more details on financing and valuation for Relievant Medsystems, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Relievant Medsystems's ticker symbol?

Relievant Medsystems does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Relievant Medsystems's stock price?

The stock price for Relievant Medsystems will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Relievant Medsystems Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
3/17/2023 Series G $361.21MM $XXX.XX $XXX.XX
10/29/2020 Series F $360.34MM $XXX.XX $XXX.XX
6/26/2018 Series E $115.23MM $XXX.XX $XXX.XX
10/11/2016 Series D-1 $90.33MM $XXX.XX $XXX.XX
3/28/2012 Series D $64.66MM $XXX.XX $XXX.XX
7/7/2009 Series C $42.55MM $XXX.XX $XXX.XX
10/22/2006 Series B and B-1 $15.52MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Relievant Medsystems

Forge green plus iconForge green minus icon

What is Relievant Medsystems funding to date?

Relievant Medsystems has raised $247.66MM with the following series:
$15.52MM for Series B and B-1, $42.55MM for Series C, $64.66MM for Series D, $90.33MM for Series D-1, $115.23MM for Series E, $360.34MM for Series F, $361.21MM for Series G, $15.52MM for Series B and B-1, $42.55MM for Series C, $64.66MM for Series D, $90.33MM for Series D-1, $115.23MM for Series E, $360.34MM for Series F, $361.21MM for Series G.
Forge green plus iconForge green minus icon

When was Relievant Medsystems founded?

Relievant Medsystems was founded in 2004.
Forge green plus iconForge green minus icon

Can you invest in Relievant Medsystems?

Relievant Medsystems is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Relievant Medsystems share pre-IPO?

If you own Relievant Medsystems pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Relievant Medsystems a publicly traded company?

Relievant Medsystems is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Relievant Medsystems in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B